Moteur de recherche d’entreprises européennes
Financement de l’UE (4 067 526 €) : Réseau européen reliant l’informatique et la génomique des lymphocytes T auxiliaires dans les tissus Hor 04/09/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Réseau européen reliant l’informatique et la génomique des lymphocytes T auxiliaires dans les tissus
ENLIGHT-TEN+ is a European Network Linking Informatics and Genomics of Helper T cells in Tissues: A crucial missing link in our current research environment is the lack of qualified individuals who possess the immunology skills to recognise and define important scientific questions amenable to -omics approaches, and also the bioinformatic expertise to interrogate and interpret the resulting Big Data appropriately. Thus, our mission is to provide cross-disciplinary training for a new generation of enthusiastic researchers who have in-depth understanding of T cell immunology and are also capable to handle large datasets. Our network of 15 beneficiaries from 10 European countries combines expertise on T cell biology with state-of-the-art technologies generating Big Data, cutting-edge bioinformatic tools including artificial intelligence, preclinical models and samples from patient cohorts. ENLIGHT-TEN+ will identify microenvironmental factors shaping the functional properties of tissue-resident T cells, which offer important therapeutic potential in various human autoimmune diseases, making them a key target for pharmaceutical companies. 15 early-stage researchers (ESRs) will be empowered to push our knowledge of tissue-resident T cells beyond the state-of-the-art which will enable the identification of novel biomarkers and support the development of advanced therapeutic concepts. The generation of Big Data is an emerging and challenging field, and there is high demand in both the academic and industrial sector for researchers to be able to analyse, integrate and exploit this rich source of information. ENLIGHT-TEN+ will combine individual strengths of innovative laboratories and enterprises from complementary disciplines to provide unique interdisciplinary training as an ideal stepping-stone for the ESRs to enter and strengthen Europe’s academia as well as pharmaceutical and bioinformatics companies, thereby placing them at the forefront of this emerging field.
| Bayer AG | 252 788 € |
| Erasmus Universitair Medisch Centrum Rotterdam | 265 620 € |
| Fundacao Gimm - Gulbenkian Institute For Molecular Medicine | 237 720 € |
| Genome Research Ltd. LBG | 210 537 € |
| Helmholtz-Zentrum FUR Infektionsforschung GmbH | 252 788 € |
| IBM Research GmbH | 281 277 € |
| Institut National de la Sante et de la Recherche Medicale | 274 802 € |
| Ludwig-Maximilians-Universitaet Muenchen | 252 788 € |
| Medizinische Universitaet Wien | 264 207 € |
| Qiagen Aarhus AS | 297 522 € |
| Stichting Radboud Universitair Medisch Centrum | 265 620 € |
| Stichting Radboud Universiteit | 0,00 € |
| Tartu Ulikool | 232 070 € |
| The Babraham Institute | 303 173 € |
| The Chancellor Masters and Scholars of the University of Cambridge | 92 636 € |
| Turun Yliopisto | 280 806 € |
| University College London | 303 173 € |
https://cordis.europa.eu/project/id/955321
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.